| ASCT | Autologous hematopoietic stem cell transplant |
| CMV | Cytomegalovirus |
| IFD | Invasive fungal disease |
| OR | Odd ratios |
| CI | Confidence intervals |
| ANC | Absolute neutrophils count |
| TRM | Transplant-related mortality |
| MM | Multiple myeloma |
| NHL | Non Hodgkin’s lymphoma |
| HL | Hodgkin’s lymphoma |
| CR | Complete remission |
| PR | Partial remission |
| SD | Stable disease |
| PD | Progressive disease |
| BEAM | Carmustine, etoposide, cytarabine, melphalan |
| FEAM | Fotemustine, etoposide, cytarabine, melphalan |
| MEL200 | Melphalan 200 mg/m2 |
| MEL140 | Melphalan 140 mg/m2 |
| MEL100 | Melphalan 100 mg/m2 |
| BSI | Bloodstream infection |
| NS | Not statistically significant |
| PCR | Polymerase-chains-reaction |
| CVC | Central venous catheter |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.